IPA is a biotechnology company based in Victoria, British Columbia, specializing in antibody discovery, protein manufacturing, and utilizing AI in biotherapeutic research.
Antibody Discovery Services
IPA offers a comprehensive range of antibody discovery services tailored to meet the diverse needs of the biotherapeutic industry. These services include target analysis, immunization, characterization, developability profiling, optimization, engineering, and preclinical services. Each service is designed to aid in the efficient and effective development of therapeutic antibodies.
Protein Manufacturing Services
IPA provides specialized protein manufacturing services essential for the advancement of various research and development projects. These services support the production of high-quality proteins necessary for numerous applications within the biopharmaceutical sector.
AI Technology in Biotherapeutic Research
IPA leverages advanced AI technology in its biotherapeutic research, particularly through its LENSai applications. These technological solutions enhance the efficiency and accuracy of biotherapeutic development, providing valuable insights and optimizing research outcomes.
IPA Collective Resource Hub
IPA maintains a resource hub known as IPA Collective, which serves as a repository for industry insights and developments. This platform offers valuable information and resources to stakeholders and participants in the biotherapeutic field.
Global Industry Events and Conferences
IPA actively engages in the global biotherapeutic sector by hosting and participating in various industry events and conferences. These engagements enable IPA to stay at the forefront of industry trends, share knowledge, and foster collaboration among professionals.